Integrated Genomics in Pediatric Oncology
We use genomics tools to decode how pediatric cancers evolve, from early mutations to relapse.
Our emerging team is part of Inserm Research Unit U1360: “Oncogenesis, Resistance, and Therapeutic Targets of Pediatric Cancers”, led by Thomas Mercher.
We are hiring—join us! Contact us.
Highlights
Our Research
Our team hunts for new genetic drivers of pediatric cancers, including somatic changes and inherited variants, using cutting-edge genomics, unique patient cohorts, and the creativity of brilliant minds.
Our Projects
Our projects are in development and will be detailed here as they take shape.
Our Team
Curious, collaborative, and multidisciplinary, our team combines computational biology and diverse perspectives to study pediatric cancers.